Literature DB >> 30145320

Developmental role of adenosine kinase for the expression of sex-dependent neuropsychiatric behavior.

D M Osborne1, U S Sandau2, A T Jones2, J W Vander Velden2, A M Weingarten2, N Etesami2, Y Huo3, H Y Shen2, D Boison2.   

Abstract

Deficits in social memory, cognition, and aberrant responses to stimulants are common among persons affected by schizophrenia and other conditions with a presumed developmental etiology. We previously found that expression changes in the adenosine metabolizing enzyme adenosine kinase (ADK) in the adult brain are associated with deficits in various cognitive domains. To distinguish between developmental and adult functions of ADK, we used two transgenic mouse lines with widespread disruption of ADK expression in the adult brain, but differences in the onset of ADK deletion. Specifically, we compared Nestin-Cre+/-:ADK-floxfl/fl (ADKΔBrain) mice with global loss of ADK in the whole brain, beginning in mid-gestation and persisting for life, with Gfa2-Cre+/-:ADK-floxfl/fl (ADKΔAstro) mice that have normal ADK expression throughout development, but lose astrocyte-specific ADK-expression in young adulthood. Because ADK-expression in adulthood is generally confined to astrocytes, adult ADKΔAstro mice show a similar expression profile of ADK in key areas of the brain related to neuropsychiatric behavior, compared to adult ADKΔBrain mice. We sought to determine a neurodevelopmental role of ADK on the expression of psychiatric behaviors in adult male and female mice. Adult ADKΔBrain mice showed significant deficits in social memory in males, significant contextual learning impairments in both sexes, and a hyper-responsiveness to amphetamine in males. In contrast, ADKΔAstro mice showed normal social memory and contextual learning but hypo-responsiveness to amphetamine in males. Our results demonstrate a key developmental role of ADK in mediating behaviors in adulthood related to neuropsychiatric disease and support the greater prevalence of these disorders among males.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Adenosine kinase; Attention deficit hyperactivity disorder; Autism; Brain development; Schizophrenia; Sex differences

Mesh:

Substances:

Year:  2018        PMID: 30145320      PMCID: PMC6867705          DOI: 10.1016/j.neuropharm.2018.08.025

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  53 in total

Review 1.  Sex differences in schizophrenia.

Authors:  Kathryn M Abel; Richard Drake; Jill M Goldstein
Journal:  Int Rev Psychiatry       Date:  2010

Review 2.  Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia.

Authors:  S Ferré; B B Fredholm; M Morelli; P Popoli; K Fuxe
Journal:  Trends Neurosci       Date:  1997-10       Impact factor: 13.837

Review 3.  Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia.

Authors:  Teresa Marie du Bois; Xu-Feng Huang
Journal:  Brain Res Rev       Date:  2006-10-02

Review 4.  Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.

Authors:  Kevin C F Fone; David J Nutt
Journal:  Curr Opin Pharmacol       Date:  2005-02       Impact factor: 5.547

Review 5.  Sex Differences in Autism Spectrum Disorder: a Review.

Authors:  Sarah L Ferri; Ted Abel; Edward S Brodkin
Journal:  Curr Psychiatry Rep       Date:  2018-03-05       Impact factor: 5.285

6.  The relationship between the neuromodulator adenosine and behavioral symptoms of autism.

Authors:  Susan A Masino; Masahito Kawamura; Louisa M Plotkin; Julia Svedova; Francis J DiMario; Inge-Marie Eigsti
Journal:  Neurosci Lett       Date:  2011-06-15       Impact factor: 3.046

Review 7.  Therapeutic potential of adenosine kinase inhibitors.

Authors:  E A Kowaluk; M F Jarvis
Journal:  Expert Opin Investig Drugs       Date:  2000-03       Impact factor: 6.206

8.  Age-Dependent Specific Changes in Area CA2 of the Hippocampus and Social Memory Deficit in a Mouse Model of the 22q11.2 Deletion Syndrome.

Authors:  Rebecca A Piskorowski; Kaoutsar Nasrallah; Anastasia Diamantopoulou; Jun Mukai; Sami I Hassan; Steven A Siegelbaum; Joseph A Gogos; Vivien Chevaleyre
Journal:  Neuron       Date:  2016-01-06       Impact factor: 17.173

9.  Assessing reproductive status/stages in mice.

Authors:  Claudia S Caligioni
Journal:  Curr Protoc Neurosci       Date:  2009-07

10.  Too little and too much: hypoactivation and disinhibition of medial prefrontal cortex cause attentional deficits.

Authors:  Marie Pezze; Stephanie McGarrity; Rob Mason; Kevin C Fone; Tobias Bast
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

View more
  5 in total

1.  Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia.

Authors:  Cassidy L Moody; Adam J Funk; Emily Devine; Ryan C Devore Homan; Detlev Boison; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

Review 2.  Metabolic Aspects of Adenosine Functions in the Brain.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Maria Grazia Tozzi
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

Review 3.  Adenosine kinase: An epigenetic modulator in development and disease.

Authors:  Madhuvika Murugan; Denise Fedele; David Millner; Enmar Alharfoush; Geetasravya Vegunta; Detlev Boison
Journal:  Neurochem Int       Date:  2021-05-05       Impact factor: 4.297

4.  Adenosine kinase inhibition promotes proliferation of neural stem cells after traumatic brain injury.

Authors:  Hoda M Gebril; Rizelle Mae Rose; Raey Gesese; Martine P Emond; Yuqing Huo; Eleonora Aronica; Detlev Boison
Journal:  Brain Commun       Date:  2020-02-20

5.  Mutation in Drosophila concentrative nucleoside transporter 1 alters spermatid maturation and mating behavior.

Authors:  Houda Ouns Maaroufi; Lucie Pauchova; Yu-Hsien Lin; Bulah Chia-Hsiang Wu; Lenka Rouhova; Lucie Kucerova; Ligia Cota Vieira; Marek Renner; Hana Sehadova; Miluse Hradilova; Michal Zurovec
Journal:  Front Cell Dev Biol       Date:  2022-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.